SearchDictionaryMobileLogin

Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control.

AuthorsC L Harper-Wynne, K Sumpter, C Ryan, K Priest, A Norton, P Ross, H E R Ford, P Johnson, M E R O'Brien
JournalLung cancer (Amsterdam, Netherlands) (Lung Cancer) Vol. 47 Issue 2 Pg. 289-90 (Feb 2005) ISSN: 0169-5002 Ireland
PMID15639729 (Publication Type: Clinical Trial, Letter, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Bacterial Vaccines
  • SRL172
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bacterial Vaccines (administration & dosage, adverse effects, therapeutic use)
  • Carcinoma, Small Cell (drug therapy)
  • Humans
  • Lung Neoplasms (drug therapy)
  • Mycobacterium
  • Survival Analysis